# Revealing age-related changes in the intraocular microenvironment and senescence modulators using aqueous humor proteomics and machine learning

**Authors:** Xiaosheng Huang, Tiansheng Chou, Xinhua Liu, Kun Zeng, Liangnan Sun, Zonghui Yan, Shaoyi Mei, Wenqun Xi, Zongyi Zhan, Yi Liu, Songguo Dong, Siqi Liu, Jun Zhao

PMC · DOI: 10.3389/fcell.2025.1583330 · Frontiers in Cell and Developmental Biology · 2025-07-16

## TL;DR

This study uses proteomics and machine learning to identify age-related changes in the eye's aqueous humor, revealing potential biomarkers and targets for age-related eye diseases.

## Contribution

The study introduces a novel framework combining AH proteomics and machine learning to identify aging proteins and senescence modulators in the eye.

## Key findings

- 179 aging-related proteins were identified and enriched in eye processes like detoxification and immune response.
- Eleven proteins serve as strong senescence signatures for predicting eye aging.
- Twenty-two proteins are potential modulators influencing the aging process in the eye.

## Abstract

In conjunction with age, aqueous humor (AH) proteomics can affect the occurrence and development of age-related eye diseases, which are poorly understood.

We characterized the proteomic changes in AH throughout the aging process to better understand the aging mechanisms of the intraocular environment.

We analyzed the AH proteomes of 33 older and 19 younger individuals using liquid chromatography–tandem mass spectrometry, from which we clustered similar expression trajectories of AH proteomics using local regression analysis. Aging proteins (APs) and their functional enrichment were evaluated using various statistical and bioinformatics methods, while aging modulators were predicted using multiple machine-learning models.

AH proteomic expression patterns exhibited various types of linear and nonlinear changes across the age groups. A set of 179 proteins identified as significant APs were enriched in various eye processes, such as detoxification, eye development, negative regulation of hydrolase activity, and humoral immune response. According to AH proteomics, hallmarks of aging include oxidative damage, defective extracellular matrices, and loss of proteostasis. A total of 11 APs were considered senescence signatures for predicting AH age with strong predictive ability. Furthermore, 22 APs were classified as modulators that may affect the aging process in the eye.

These findings establish a framework for age-related changes in the AH proteome and provide potential senescence biomarkers and therapeutic targets for age-related eye diseases.

## Full-text entities

- **Genes:** LCN2 (lipocalin 2) [NCBI Gene 3934] {aka 24p3, MSFI, NGAL, p25}, OMG (oligodendrocyte myelin glycoprotein) [NCBI Gene 4974] {aka OMGP}, APOH (apolipoprotein H) [NCBI Gene 350] {aka B2G1, B2GP1, BG}, HSPB1 (heat shock protein family B (small) member 1) [NCBI Gene 3315] {aka CMT2F, HEL-S-102, HMN2B, HMND3, HS.76067, HSP27}, HYOU1 (hypoxia up-regulated 1) [NCBI Gene 10525] {aka GRP-170, Grp170, HSP12A, IMD59, ORP-150, ORP150}, LTBP3 (latent transforming growth factor beta binding protein 3) [NCBI Gene 4054] {aka DASS, GPHYSD3, LTBP-3, LTBP2, STHAG6, pp6425}, PRDX2 (peroxiredoxin 2) [NCBI Gene 7001] {aka HEL-S-2a, NKEF-B, NKEFB, PRP, PRX2, PRXII}, SH2B2 (SH2B adaptor protein 2) [NCBI Gene 10603] {aka APS}, GSTP1 (glutathione S-transferase pi 1) [NCBI Gene 2950] {aka DFN7, FAEES3, GST3, GSTP, GSTP1-1, HEL-S-22}, APOA1 (apolipoprotein A1) [NCBI Gene 335] {aka AMYLD3, HPALP2, apo(a)}, HSPA8 (heat shock protein family A (Hsp70) member 8) [NCBI Gene 3312] {aka HEL-33, HEL-S-72p, HSC54, HSC70, HSC71, HSP71}, LEFTY2 (left-right determination factor 2) [NCBI Gene 7044] {aka EBAF, LEFTA, LEFTYA, TGFB4}, SIAE (sialic acid acetylesterase) [NCBI Gene 54414] {aka AIS6, CSE-C, CSEC, LSE, YSG2}, RBP4 (retinol binding protein 4) [NCBI Gene 5950] {aka MCOPCB10, RDCCAS}, LYZ (lysozyme) [NCBI Gene 4069] {aka AMYLD5, LYZF1, LZM}, CTBS (chitobiase) [NCBI Gene 1486] {aka CTB}, COL1A2 (collagen type I alpha 2 chain) [NCBI Gene 1278] {aka EDSARTH2, EDSCV, OI4}, LRG1 (leucine rich alpha-2-glycoprotein 1) [NCBI Gene 116844] {aka HMFT1766, LRG}, NPTX2 (neuronal pentraxin 2) [NCBI Gene 4885] {aka NARP, NP-II, NP2}, PTPRG (protein tyrosine phosphatase receptor type G) [NCBI Gene 5793] {aka HPTPG, PTPG, R-PTP-GAMMA, RPTPG}, HEG1 (heart development protein with EGF like domains 1) [NCBI Gene 57493] {aka HEG, MST112, MSTP112}, AZGP1 (alpha-2-glycoprotein 1, zinc-binding) [NCBI Gene 563] {aka ZA2G, ZAG}, ABI3BP (ABI family member 3 binding protein) [NCBI Gene 25890] {aka NESHBP, TARSH}, PPARA (peroxisome proliferator activated receptor alpha) [NCBI Gene 5465] {aka NR1C1, PPAR, PPAR-alpha, PPARalpha, hPPAR}, GRN (granulin precursor) [NCBI Gene 2896] {aka CLN11, FTD2, GEP, GP88, PCDGF, PEPI}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, MMP14 (matrix metallopeptidase 14) [NCBI Gene 4323] {aka MMP-14, MMP-X1, MT-MMP, MT-MMP 1, MT1-MMP, MT1MMP}, COL6A3 (collagen type VI alpha 3 chain) [NCBI Gene 1293] {aka BTHLM1, BTHLM1C, DYT27, UCMD1, UCMD1C}, LEAP2 (liver enriched antimicrobial peptide 2) [NCBI Gene 116842] {aka LEAP-2}, TXN (thioredoxin) [NCBI Gene 7295] {aka TRDX, TRX, TRX1, TXN1, Trx80}, KNG1 (kininogen 1) [NCBI Gene 3827] {aka BDK, BK, HAE6, HK, HMWK, KNG}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, TPP1 (tripeptidyl peptidase 1) [NCBI Gene 1200] {aka CLN2, GIG1, LPIC, SCAR7, TPP-1}, NELL2 (neural EGFL like 2) [NCBI Gene 4753] {aka NRP2}, VTN (vitronectin) [NCBI Gene 7448] {aka V75, VN, VNT}, CRYGS (crystallin gamma S) [NCBI Gene 1427] {aka CRYG8, CTRCT20}, LINGO1 (leucine rich repeat and Ig domain containing 1) [NCBI Gene 84894] {aka LERN1, LRRN6A, MRT64, UNQ201}, NRSN2 (neurensin 2) [NCBI Gene 80023] {aka C20orf98, dJ1103G7.6}, THAP4 (THAP domain containing 4) [NCBI Gene 51078] {aka CGI-36, Nb(III), PP238}, TFPI2 (tissue factor pathway inhibitor 2) [NCBI Gene 7980] {aka PP5, REF1, TFPI-2}, DNASE2 (deoxyribonuclease 2, lysosomal) [NCBI Gene 1777] {aka AIPCS, DNASE2A, DNL, DNL2}, HSPA6 (heat shock protein family A (Hsp70) member 6) [NCBI Gene 3310] {aka HSP70B'}, GOT1 (glutamic-oxaloacetic transaminase 1) [NCBI Gene 2805] {aka AST, AST1, ASTQTL1, GIG18, SGOT, cAspAT}, WIF1 (Wnt inhibitory factor 1) [NCBI Gene 11197] {aka WIF-1}, PRDX6 (peroxiredoxin 6) [NCBI Gene 9588] {aka 1-Cys, AOP2, HEL-S-128m, LPCAT-5, NSGPx, PRX}, SPINK1 (serine peptidase inhibitor Kazal type 1) [NCBI Gene 6690] {aka PCTT, PSTI, Spink3, TATI, TCP}, SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}, SAA4 (serum amyloid A4, constitutive) [NCBI Gene 6291] {aka C-SAA, CSAA}, PRDX1 (peroxiredoxin 1) [NCBI Gene 5052] {aka MSP23, NKEF-A, NKEFA, PAG, PAGA, PAGB}, CASP14 (caspase 14) [NCBI Gene 23581] {aka ARCI12, caspase-14}, TGFB2 (transforming growth factor beta 2) [NCBI Gene 7042] {aka CAEND2, G-TSF, LDS4, TGF-beta2}, APOA2 (apolipoprotein A2) [NCBI Gene 336] {aka APOA2D, Apo-AII, ApoA-II, apoAII}, NOTCH1 (notch receptor 1) [NCBI Gene 4851] {aka AOS5, AOVD1, TAN1, hN1}, CTSD (cathepsin D) [NCBI Gene 1509] {aka CLN10, CPSD, HEL-S-130P}, GSTO1 (glutathione S-transferase omega 1) [NCBI Gene 9446] {aka GSTO 1-1, GSTTLp28, HEL-S-21, P28, SPG-R}, COA3 (cytochrome c oxidase assembly factor 3) [NCBI Gene 28958] {aka CCDC56, COX25, HSPC009, MC4DN14, MITRAC12, hCOA3}
- **Diseases:** hyperuricemia (MESH:D033461), ametropia (MESH:D012030), myopic (MESH:D001251), keratitis (MESH:D007634), retinal vein occlusion (MESH:D012170), high myopia (MESH:D009216), rheumatic disease (MESH:D012216), Lens Opacities (MESH:D002386), ARCs (MESH:C563333), glaucoma (MESH:D005901), hyperthyroidism (MESH:D006980), ARC (MESH:D000386), Age-related ocular diseases (MESH:D008569), systemic diseases (MESH:D034721), AH (MESH:C562390), hypercapnia (MESH:D006935), chronic diseases (MESH:D002908), Alzheimer's and Parkinson's diseases (MESH:D010300), pseudoexfoliation syndrome (MESH:D017889), uveitis (MESH:D014605), age-related diseases (MESH:D010024), AL (MESH:C537791), diabetic retinopathy (MESH:D003930), Age-related eye diseases (MESH:D005128), mitochondrial dysfunction (MESH:D028361), age-related macular degeneration (MESH:D008268), ocular traumas (MESH:D014947), inflammation (MESH:D007249)
- **Chemicals:** reactive oxygen species (MESH:D017382), carbohydrate (MESH:D002241), dithiothreitol (MESH:D004229), phenylmethylsulfonyl fluoride (MESH:D010664), FA (MESH:D005492), ethylenediaminetetraacetic acid (MESH:D004492), ACN (MESH:C084683), pyruvate (MESH:D019289), cholesterol (MESH:D002784), iodoacetamide (MESH:D007460), oxygen (MESH:D010100), cysteine (MESH:D003545), ammonium bicarbonate (MESH:C027043), Peptide (MESH:D010455), superoxide (MESH:D013481), hydrogen peroxide (MESH:D006861), methionine (MESH:D008715), AA (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12307501/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12307501/full.md

## References

37 references — full list in the complete paper: https://tomesphere.com/paper/PMC12307501/full.md

---
Source: https://tomesphere.com/paper/PMC12307501